Skye Bioscience (SKYE) Stock Chart & Stock Price History $1.90 -0.17 (-8.21%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.94 +0.05 (+2.37%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Skye Bioscience Stock Price Performance The Skye Bioscience (SKYE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.25%, with a year-to-date return of -25.49%. In the past month, the stock has increased 7.04%, reflecting recent market activity. As of the latest close, Skye Bioscience traded at $1.90 with a market cap of $58.85 million and volume of 318,876 shares. Receive SKYE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.16%1 Month Performance+7.04%3 Month Performance-34.26%Year-To-Date Performance-25.49%1 Year Performance-84.25% SKYE Stock Chart for Sunday, May, 25, 2025 SKYE Chart by TradingView Skye Bioscience Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$2.07$1.90-8.21%$2.10$1.88318,876 shs$58.85 million05/23/2025$2.07$1.90-8.21%$1.81$1.63320,782 shs$61.02 million05/22/2025$2.20$2.07-5.69%$2.20$2.03270,063 shs$64.12 million05/22/2025$2.20$2.08-5.47%$1.81$1.63320,782 shs$61.02 million05/21/2025$1.96$2.20+11.88%$1.81$1.63320,782 shs$61.02 million05/21/2025$1.96$2.21+12.64%$2.22$1.97246,046 shs$68.46 million05/20/2025$2.07$1.96-4.99%$1.81$1.63320,782 shs$62.26 million05/20/2025$2.07$1.97-4.60%$2.13$1.89260,249 shs$61.02 million05/19/2025$1.87$2.07+10.43%$1.81$1.63320,782 shs$62.26 million05/19/2025$1.87$2.15+14.97%$2.20$1.87216,019 shs$66.60 million Get the Latest News and Ratings for SKYE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. 05/16/2025$1.91$1.87-1.84%$2.03$1.78220,627 shs$57.92 million05/16/2025$1.91$1.88-1.57%$1.81$1.63320,782 shs$62.26 million05/15/2025$1.90$1.91+0.26%$1.81$1.63320,782 shs$56.07 million05/15/2025$1.90$2.01+5.79%$2.04$1.81139,428 shs$62.26 million05/14/2025$1.94$1.90-2.06%$2.10$1.90105,448 shs$58.85 million05/14/2025$1.94$1.94+0.05%$1.81$1.63320,782 shs$56.07 million05/13/2025$2.05$1.94-5.37%$1.81$1.63320,782 shs$56.07 million05/13/2025$2.05$1.94-5.37%$2.04$1.91191,385 shs$60.09 million05/12/2025$1.81$2.05+13.26%$2.07$1.78245,401 shs$63.50 million05/12/2025$1.81$2.07+14.09%$1.81$1.63320,782 shs$56.07 million05/09/2025$1.78$1.81+1.74%$1.95$1.68287,575 shs$56.07 million05/09/2025$1.78$1.90+6.91%$1.81$1.63320,782 shs$61.64 million05/08/2025$1.82$1.78-1.98%$1.81$1.63320,782 shs$61.64 million05/08/2025$1.82$1.79-1.38%$1.82$1.70249,637 shs$55.45 million05/07/2025$1.85$1.82-2.10%$1.81$1.63320,782 shs$61.64 million05/07/2025$1.85$1.82-1.83%$1.90$1.78165,546 shs$56.37 million05/06/2025$1.99$1.85-6.60%$1.81$1.63320,782 shs$61.64 million05/06/2025$1.99$1.86-6.30%$1.99$1.85161,500 shs$57.61 million05/05/2025$2.24$1.99-11.38%$1.81$1.63320,782 shs$67.53 million05/05/2025$2.24$1.99-11.16%$2.30$1.98224,316 shs$61.64 million05/02/2025$2.03$2.24+10.34%$2.27$2.04261,956 shs$69.38 million05/02/2025$2.03$2.25+10.74%$1.81$1.63320,782 shs$67.53 million05/01/2025$2.02$2.03+0.74%$2.18$1.95276,579 shs$62.88 million05/01/2025$2.02$2.04+1.24%$1.81$1.63320,782 shs$67.53 million04/30/2025$2.00$2.02+0.75%$1.81$1.63320,782 shs$56.38 million04/30/2025$2.00$2.18+9.00%$2.20$1.91302,081 shs$67.53 million04/29/2025$1.91$2.00+4.77%$2.11$1.87439,807 shs$61.95 million04/29/2025$1.91$2.01+5.03%$1.81$1.63320,782 shs$56.38 million04/28/2025$1.78$1.91+7.55%$1.81$1.63320,782 shs$56.38 million04/28/2025$1.78$1.91+7.61%$1.91$1.76211,658 shs$59.16 millionBuffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now.04/25/2025$1.79$1.78-0.73%$1.81$1.63320,782 shs$55.45 million04/25/2025$1.79$1.82+1.79%$1.92$1.75415,677 shs$56.37 million04/24/2025$1.71$1.79+4.68%$2.85$2.6361,166 shs$44.45 million04/24/2025$1.71$1.79+4.80%$1.81$1.63330,797 shs$55.45 million Related Companies TSVT Stock Price Chart INZY Stock Price Chart GLUE Stock Price Chart PVLA Stock Price Chart LFCR Stock Price Chart TNGX Stock Price Chart GOSS Stock Price Chart CRVS Stock Price Chart AQST Stock Price Chart AVIR Stock Price Chart Receive SKYE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SKYE) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skye Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skye Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.